Clinical Trial Detail

NCT ID NCT03845166
Title A Study of XL092 in Subjects With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Exelixis
Indications

renal cell carcinoma

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

XL092

Age Groups: senior adult

No variant requirements are available.